Have your provider send your GLP-1 prescription for a 3-month supply electronically to Evernorth EnGuide Pharmacy
And see their impressive TRT before and after photos
IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
This section synthesizes evidence on the systemic effects of metformin, sodiumglucose cotransporter 2 inhibitors (SGLT-2Is), GLP-1RAs, nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs), and dual incretin agonists across organ systems
The patient should be advised to stop treatment if black coloured ulceration or systemic flu-like symptoms occur
Although there is no absolute contraindication to using both medications together, their opposing metabolic effectsparticularly on appetite, weight, and blood glucoserequire careful monitoring and individualised management
